150 related articles for article (PubMed ID: 31825183)
1. CD15, CD30, and PAX5 evaluation in Hodgkin's lymphoma on fine-needle aspiration cytology samples.
Cozzolino I; Vitagliano G; Caputo A; Montella M; Franco R; Ciancia G; Selleri C; Zeppa P
Diagn Cytopathol; 2020 Mar; 48(3):211-216. PubMed ID: 31825183
[TBL] [Abstract][Full Text] [Related]
2. CD30, CD15, CD50, and PAX5 Expressions as Diagnostic Markers for Hodgkin Lymphoma (HL) and Systemic Anaplastic Large Cell Lymphoma (sALCL).
Ranuhardy D; Suzanna E; Sari RM; Hadisantoso DW; Andalucia R; Abdillah A
Acta Med Indones; 2018 Apr; 50(2):104-109. PubMed ID: 29950528
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.
Gharbaran R; Goy A; Tanaka T; Park J; Kim C; Hasan N; Vemulapalli S; Sarojini S; Tuluc M; Nalley K; Bhattacharyya P; Pecora A; Suh KS
J Hematol Oncol; 2013 Aug; 6():62. PubMed ID: 23988031
[TBL] [Abstract][Full Text] [Related]
4. Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.
Eberle FC; Song JY; Xi L; Raffeld M; Harris NL; Wilson WH; Pittaluga S; Jaffe ES
Am J Surg Pathol; 2012 May; 36(5):716-25. PubMed ID: 22367293
[TBL] [Abstract][Full Text] [Related]
5. Peripheral T-cell lymphomas expressing CD30 and CD15.
Barry TS; Jaffe ES; Sorbara L; Raffeld M; Pittaluga S
Am J Surg Pathol; 2003 Dec; 27(12):1513-22. PubMed ID: 14657710
[TBL] [Abstract][Full Text] [Related]
6. Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators.
Cho RJ; McCalmont TH; Ai WZ; Fox LP; Treseler P; Pincus LB
J Cutan Pathol; 2012 Jun; 39(6):651-8. PubMed ID: 22324490
[TBL] [Abstract][Full Text] [Related]
7. IMP3 as a supplemental diagnostic marker for Hodgkin lymphoma.
Tang H; Wei Q; Ge J; Jian W; Liu J; Zhong L; Fu B; Zhao T
Hum Pathol; 2013 Oct; 44(10):2167-72. PubMed ID: 23845468
[TBL] [Abstract][Full Text] [Related]
8. Immunoprofile of Hodgkin's lymphoma in India.
Patkar N; Mehta J; Kulkarni B; Pande R; Advani S; Borges A
Indian J Cancer; 2008; 45(2):59-63. PubMed ID: 18626150
[TBL] [Abstract][Full Text] [Related]
9. T-cell variant of classical Hodgkin's lymphoma with nodal and cutaneous manifestations demonstrated by single-cell polymerase chain reaction.
Willenbrock K; Ichinohasama R; Kadin ME; Miura I; Terui T; Meguro K; Fukuhara O; DeCoteau JF; Hansmann ML
Lab Invest; 2002 Sep; 82(9):1103-9. PubMed ID: 12218070
[TBL] [Abstract][Full Text] [Related]
10. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.
Hansmann ML; Fellbaum C; Hui PK; Lennert K
Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946
[TBL] [Abstract][Full Text] [Related]
11. CD20 positivity in classical Hodgkin's lymphoma: Diagnostic challenge or targeting opportunity.
Barakzai MA; Pervez S
Indian J Pathol Microbiol; 2009; 52(1):6-9. PubMed ID: 19136769
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic molecule-positive classical Hodgkin's lymphoma: a clinicopathological comparison with cytotoxic molecule-positive peripheral T-cell lymphoma of not otherwise specified type.
Asano N; Kinoshita T; Tamaru J; Ohshima K; Yoshino T; Niitsu N; Tsukamoto N; Hirabayashi K; Izutsu K; Taniwaki M; Morishima Y; Nakamura S
Haematologica; 2011 Nov; 96(11):1636-43. PubMed ID: 21859738
[TBL] [Abstract][Full Text] [Related]
13. Cytomorphologic differentiation of Hodgkin's lymphoma and Ki-1+ anaplastic large cell lymphoma in fine needle aspirates.
Mourad WA; al Nazer M; Tulbah A
Acta Cytol; 2003; 47(5):744-8. PubMed ID: 14526672
[TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of B-cell-specific activator protein of H/RS cell in classical Hodgkin's Lymphoma].
Zhou X; Zhao T; Qi Z; Liu G; Zhu M
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1532-5. PubMed ID: 12609061
[TBL] [Abstract][Full Text] [Related]
15. The role of CD30, CD40 and CD95 in the regulation of proliferation and apoptosis in classical Hodgkin's lymphoma.
Kim LH; Eow GI; Peh SC; Poppema S
Pathology; 2003 Oct; 35(5):428-35. PubMed ID: 14555388
[TBL] [Abstract][Full Text] [Related]
16. Hodgkin's lymphoma: diagnostic difficulties in fine-needle aspiration cytology.
Das DK; Francis IM; Sharma PN; Sathar SA; John B; George SS; Mallik MK; Sheikh ZA; Haji BE; Pathan SK; Madda JP; Mirza K; Ahmed MS; Junaid TA
Diagn Cytopathol; 2009 Aug; 37(8):564-73. PubMed ID: 19373880
[TBL] [Abstract][Full Text] [Related]
17. Sequential development of Hodgkin's disease and CD30+ diffuse large B-cell lymphoma in a patient with MALT-type lymphoma: evidence of different clonal origin of single microdissected Reed-Sternberg cells.
Parrens M; Vergier B; Fitoussi O; Lahet C; Belleannee G; Marit G; Dubus P; de Mascarel A; Delfau-Larue MH; Merlio JP
Am J Surg Pathol; 2002 Dec; 26(12):1634-42. PubMed ID: 12459631
[TBL] [Abstract][Full Text] [Related]
18. Hodgkin's and non-Hodgkin's lymphoma: spectrum of morphologic and immunophenotypic overlap.
Elgin J; Phillips JG; Reddy VV; Gibbs PO; Listinsky CM
Ann Diagn Pathol; 1999 Oct; 3(5):263-75. PubMed ID: 10556472
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of CD30 remains negative in nodular lymphocyte-predominant Hodgkin's disease using enhanced antigen retrieval.
Roberts C; Jack F; Angus B; Reid A; Thompson WD
Histopathology; 2002 Feb; 40(2):166-70. PubMed ID: 11952861
[TBL] [Abstract][Full Text] [Related]
20. A case of Langerhans' cell histiocytosis associated with Hodgkin's lymphoma: Fine-needle aspiration cytologic and histopathological features.
Das DK; Sheikh ZA; Alansary TA; Amir T; Al-Rabiy FN; Junaid TA
Diagn Cytopathol; 2016 Feb; 44(2):128-32. PubMed ID: 26608102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
